Independent contribution of HLA-DRB1 and TNFα promoter polymorphisms to the susceptibility to Crohn's disease

Genes and Immunity

Volumn 1, Issue 6, 2000, Pages 351-357

  Kawasaki, A ^a   Tsuchiya, N ^a   Hagiwara, K ^a   Takazoe, M ^b   Tokunaga, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Social Hlth Ins Medical Center   (Japan)

Author keywords

Crohn's disease; HLA DRB1; Polymorphism; TNF promoter

Indexed keywords

HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; LEUKOCYTE ANTIGEN; PRIMER DNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOLOGY; JAPAN; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION;

ADULT; ALLELES; ANTIGENS, CD; BASE SEQUENCE; CASE-CONTROL STUDIES; CROHN DISEASE; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034252209     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363689     Document Type: Article

References (36)

1. Satsangi J, Jewell DP, Bell JI. The genetics of inflammatory bowel disease. Gut 1997; 40: 572-574.
2. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988; 29: 990-996.
3. Hugot J-P, Laurent-Puig P, Gower-Rousseau C et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821-823.
4. Satsangi J, Parkes M, Louis E et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996; 14: 199-202.
5. Cho JH, Nicolae DL, Gold LH et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci USA 1998; 95: 7502-7507.
6. Hampe J, Schreiber S, Shaw SH et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 1999; 64: 808-816.
7. Danzé PM, Colombel J-F, Jacquot S et al. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 1996; 39: 69-72.
8. Reinshagen M, Loeliger C, Kuehnl P et al. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 1996; 38: 538-542.
9. Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci USA 1996; 93: 5094-5098.
10. Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 1995; 109: 1462-1467.
11. Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel disease. Tissue Antigens 1999; 53: 350-358.
12. Reimund J-M, Wittersheim C, Dumont S et al. Increased production of tumour necrosis factor-α interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996; 39: 684-689.
13. Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut 1998; 43: 203-209.
14. Schreiber S, Nikolaus S, Hampe J et al. Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease. Lancet 1999; 353: 459-461.
15. Targan SR, Hanauer SB, van Deventer SJ et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-1035.
16. Bidwell J, Keen L, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3-19.
17. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
18. Louis E, Satsangi J, Roussomoustakaki M et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996; 39: 705-710.
19. Bouma G, Xia B, Crusius JBA, Bioque G, Koutroubakis I, von Blomberg BME. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 103: 391-396.
20. Bouma G, Oudkerk Pool M, Crusius JBA et al. Evidence for genetic heterogeneity in IBD. HLA genes in the predisposition to suffer from ulcerative colitis and Crohn's disease. Clin Exp Immunol 1997; 109: 175-179.
21. Louis E, Peeters M, Franchimont D et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000; 119: 64-68.
22. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 2000; 1: 185-190.
23. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110: 1053-1060.
24. Yang H, Plevy SE, Taylor K et al. Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analysis. Gut 1999; 44: 519-526.
25. Higuchi T, Seki N, Kamizono S et al. Polymorphism of the 5′-flanking region of the human tumor necrosis factor (TNF)-α gene in Japanese. Tissue Antigens 1998; 51: 605-612.
26. Uglialoro AM, Turbay D, Pesavento PA et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-α gene promoter. Tissue Antigens 1998; 52: 359-367.
27. Negoro K, Kinouchi Y, Hiwatashi N et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999; 117: 1062-1068.
28. Matsushita M, Tsuchiya N, Nakayama T et al. Allele typing of human TNFA 5′-flanking region using polymerase chain reaction-preferential homoduplex formation assay (PCR-PHFA): linkage disequilibrium with HLA class I and class II genes in Japanese. Tissue Antigens 1999; 54: 478-484.
29. Komata T, Tsuchiya N, Matsushita M, Hagiwara K, Tokunaga K. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 1999; 53: 527-533.
30. Shibue T, Tsuchiya N, Komata T et al. Tumor necrosis factor a 5′-flanking region, TNF receptor II and HLA-DRB1 genotypes in the Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 753-757.
31. Mulcahy B, Waldron-Lynch F, McDermott MF et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996; 59: 676-683.
32. Bali D, Gourley S, Kostyu DD et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immun 1999; 1: 28-36.
33. Rood MJ, van Krugten MV, Zanelli E et al TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-134.
34. Skoog T, van't Hooft FM, Kallin B et al. A common functional polymorphism (C->A substitution at position -863) in the promoter region of the tumour necrosis factor-α (TNF-α) gene associated with reduced circulating levels of TNF-α. Hum Mol Genet 1999; 8: 1443-1449.
35. Tokunaga K, Imanishi T, Takahashi K, Juji T. On the origin and dispersal of East Asian populations as viewed from HLA haplotypes. In: Akazawa T, Szathmary EJ (eds). Prehistoric Mongoloid Dispersals. Oxford University Press: Oxford, 1996, pp 187-197.
36. Kawai S, Maekawajiri S, Tokunaga K et al. Routine low and high resolution typing of the HLA-DRB gene using the PCR-MPH (microtitre plate hybridization) method. Eur J Immunogenet 1996; 23: 471-486.